Ok, I haven't looked at what was said. But this was said 7 days ago.
No, it wasn't. It is dated today and Gary opens by saying "we got to present our data in a room full of people..." - He's referring to yesterday's appearance at the American Society of Hematology Conference.
If you listen to what I provided you, the CEO says they will have enough data to go to the FDA after March next year, expecting agreement from the FDA for how to proceed with the Ph3, by around the middle of 2025. That from the horse's mouth, so to speak.
SNT Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)